Determination of HER2 Gene Amplification by Chromogenic In Situ Hybridization (CISH) in Archival Breast Carcinoma
Open Access
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 15 (6) , 657-665
- https://doi.org/10.1038/modpathol.3880582
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- HER-2/neu Testing in Breast Carcinoma: A Combined Immunohistochemical and Fluorescence In Situ Hybridization ApproachLaboratory Investigation, 2000
- Immunohistochemical Determination of HER-2/neu Expression in Invasive Breast CarcinomaAmerican Journal of Clinical Pathology, 2000
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With SurvivalMolecular Diagnosis, 2000
- C-erbB-2 immunostaining: problems with interpretation.Journal of Clinical Pathology, 1994
- Analysis of cerbB2 expression using a panel of 6 commercially available antibodiesPathology, 1994
- Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Studies of the HER-2/neu Proto-oncogene in Human Breast CancerCancer Investigation, 1990
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989